Page last updated: 2024-10-25

ciprofloxacin and Bone Marrow Diseases

ciprofloxacin has been researched along with Bone Marrow Diseases in 2 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Bone Marrow Diseases: Diseases involving the BONE MARROW.

Research Excerpts

ExcerptRelevanceReference
"To study whether oral ciprofloxacin would be as effective in preventing bacterial infections in severely myelosuppressed patients as selective antibiotic modulation of the gut flora with neomycin/polymyxin B sulfate/nalidixic acid (NPN)."5.07Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora. ( Akard, L; Allen, SD; Black, JR; Cromer, M; Jansen, J; Wheat, LJ, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Satti, L1
Abbasi, S1
Sattar, A1
Ikram, A1
Manzar, MA1
Khalid, MM1
Jansen, J1
Cromer, M1
Akard, L1
Black, JR1
Wheat, LJ1
Allen, SD1

Trials

1 trial available for ciprofloxacin and Bone Marrow Diseases

ArticleYear
Infection prevention in severely myelosuppressed patients: a comparison between ciprofloxacin and a regimen of selective antibiotic modulation of the intestinal flora.
    The American journal of medicine, 1994, Volume: 96, Issue:4

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Bone Marrow Diseases; Ciprofloxacin; Drug Therapy, Co

1994

Other Studies

1 other study available for ciprofloxacin and Bone Marrow Diseases

ArticleYear
Bone marrow infection with Mycobacterium fortuitum in a diabetic patient.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2011, Volume: 21, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bone Marrow; Bone Marrow Diseases; Cip

2011